| Concordance of the toxicity of pharmaceuticals in humans and in animals H Olson, G Betton, D Robinson, K Thomas, A Monro, G Kolaja, P Lilly, ... Regulatory Toxicology and Pharmacology 32 (1), 56-67, 2000 | 2294 | 2000 |
| The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies JM Goldman, AS Murr, RL Cooper Birth Defects Research Part B: Developmental and Reproductive Toxicology 80 …, 2007 | 909 | 2007 |
| Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation KW Powers, SC Brown, VB Krishna, SC Wasdo, BM Moudgil, SM Roberts Toxicological Sciences 90 (2), 296-303, 2006 | 785 | 2006 |
| Thalidomide: the tragedy of birth defects and the effective treatment of disease JH Kim, AR Scialli Toxicological sciences 122 (1), 1-6, 2011 | 710 | 2011 |
| Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles P Borm, FC Klaessig, TD Landry, B Moudgil, J Pauluhn, K Thomas, ... Toxicological Sciences 90 (1), 23-32, 2006 | 697 | 2006 |
| Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles JS Tsuji, AD Maynard, PC Howard, JT James, C Lam, DB Warheit, ... Toxicological sciences 89 (1), 42-50, 2006 | 630 | 2006 |
| Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium PT Sager, G Gintant, JR Turner, S Pettit, N Stockbridge American heart journal 167 (3), 292-300, 2014 | 556 | 2014 |
| Trophic magnification factors: considerations of ecology, ecosystems, and study design K Borgå, KA Kidd, DCG Muir, O Berglund, JM Conder, FAPC Gobas, ... Integrated environmental assessment and management 8 (1), 64-84, 2012 | 495 | 2012 |
| Research strategies for safety evaluation of nanomaterials, Part I: evaluating the human health implications of exposure to nanoscale materials K Thomas, P Sayre Toxicological sciences 87 (2), 316-321, 2005 | 476 | 2005 |
| Weight of evidence: a review of concept and methods DL Weed Risk Analysis: An International Journal 25 (6), 1545-1557, 2005 | 448 | 2005 |
| The fish embryo toxicity test as an animal alternative method in hazard and risk assessment and scientific research MR Embry, SE Belanger, TA Braunbeck, M Galay-Burgos, M Halder, ... Aquatic toxicology 97 (2), 79-87, 2010 | 430 | 2010 |
| Risk assessment of combined exposure to multiple chemicals: a WHO/IPCS framework ME Meek, AR Boobis, KM Crofton, G Heinemeyer, M Van Raaij, C Vickers Regul Toxicol Pharmacol 60 (2 suppl 1), S1-S14, 2011 | 404 | 2011 |
| The comprehensive in vitro proarrhythmia assay (CiPA) initiative—update on progress T Colatsky, B Fermini, G Gintant, JB Pierson, P Sager, Y Sekino, ... Journal of pharmacological and toxicological methods 81, 15-20, 2016 | 385 | 2016 |
| Evolution of science-based uncertainty factors in noncancer risk assessment ML Dourson, SP Felter, D Robinson Regulatory Toxicology and Pharmacology 24 (2), 108-120, 1996 | 363 | 1996 |
| Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs MP Holsapple, WH Farland, TD Landry, NA Monteiro-Riviere, JM Carter, ... Toxicological Sciences 88 (1), 12-17, 2005 | 349 | 2005 |
| Biomarkers of exposure: a case study with inorganic arsenic MF Hughes Environmental health perspectives 114 (11), 1790-1796, 2006 | 340 | 2006 |
| A multi-laboratory evaluation of a common in vitro pepsin digestion assay protocol used in assessing the safety of novel proteins K Thomas, M Aalbers, GA Bannon, M Bartels, RJ Dearman, DJ Esdaile, ... Regulatory Toxicology and Pharmacology 39 (2), 87-98, 2004 | 337 | 2004 |
| Identification of putative gene based markers of renal toxicity. RP Amin, AE Vickers, F Sistare, KL Thompson, RJ Roman, M Lawton, ... Environmental health perspectives 112 (4), 465-479, 2004 | 334 | 2004 |
| Mode of action in relevance of rodent liver tumors to human cancer risk MP Holsapple, HC Pitot, SH Cohen, AR Boobis, JE Klaunig, T Pastoor, ... Toxicological Sciences 89 (1), 51-56, 2006 | 294 | 2006 |
| International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment K Blinova, Q Dang, D Millard, G Smith, J Pierson, L Guo, M Brock, HR Lu, ... Cell reports 24 (13), 3582-3592, 2018 | 289 | 2018 |
